Medical Instruments & Supplies
Bioject Reports First Quarter 2010 Financial Results
Published in Vaccine Weekly, May 26th, 2010
For the quarter ended March 31, 2010, Bioject reported revenues of $1.2 million compared to $2.0 million reported in the comparable year-ago quarter. Product sales for the first quarter of 2010 were $1.1 million compared to $1.9 million in the year-ago quarter. License and technology fees for the first quarter of 2010 were $96,000 compared to $128,000 in the comparable year ago period. Operating expenses for the first quarter of 2010 were $1.7 million compared to $2.2 million in the comparable 2009...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-05-26)
More Articles from Vaccine Weekly
- Streptococcus
New findings from University of Maine in the area of Streptococcus published - Biological Products
Reports from National Institute for Medical Research advance knowledge in biological products - Biological Products
Research on biological products discussed by scientists at University of British Columbia - Biological Products
BioSante Pharmaceuticals Reports Recent Developments and First Quarter Financial Results - Hemic and Immune Systems
Cheese found to improve the immune response of the elderly - Quality of Life
Data from G.L. Mortensen and colleagues advance knowledge in quality of life - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
